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Abstract
Genome-wide association studies have identified multiple novel genomic loci associated
with vascular diseases. Many of these loci are common non-coding variants that affect the
expression of disease-relevant genes within coronary vascular cells. To identify such genes
on a genome-wide level, we performed deep transcriptomic analysis of genotyped primary
human coronary artery smooth muscle cells (HCASMCs) and coronary endothelial cells
(HCAECs) from the same subjects, including splicing Quantitative Trait Loci (sQTL), allele-
specific expression (ASE), and colocalization analyses. We identified sQTLs for TARS2,
YAP1, CFDP1, and STAT6 in HCASMCs and HCAECs, and 233 ASE genes, a subset of
which are also GTEx eGenes in arterial tissues. Colocalization of GWAS association signals
for coronary artery disease (CAD), migraine, stroke and abdominal aortic aneurysm with
GTEx eGenes in aorta, coronary artery and tibial artery discovered novel candidate risk
genes for these diseases. At the CAD and stroke locus tagged by rs2107595 we demon-
strate colocalization with expression of the proximal gene TWIST1. We show that disrupting
the rs2107595 locus alters TWIST1 expression and that the risk allele has increased binding
of the NOTCH signaling protein RBPJ. Finally, we provide data that TWIST1 expression
influences vascular SMC phenotypes, including proliferation and calcification, as a potential
mechanism supporting a role for TWIST1 in CAD.
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Author summary
Genome-wide association studies (GWAS) have identified hundreds of genetic variants
that are associated with human vascular disease including coronary artery disease. These
are predominantly common single nucleotide polymorphisms (SNPs) in non-coding
regions, which makes the identification of the causal genes and their underlying connec-
tion to pathophysiology challenging. Mapping of expression quantitative trait loci
(eQTLs) has been performed to associate GWAS SNPs with risk genes in vascular cells
and tissues. However, atherosclerotic vascular tissues contain multiple cell types. We
perform deep transcriptomic profiling of genotyped human-derived vascular cells–
endothelial cells and smooth muscle cells–and use splicing quantitative trait locus,
allele-specific expression, and colocalization analyses to annotate genetic variants associ-
ated with vascular diseases and gain insight into their potential function in a cell-type
specific manner. Based on these analyses, we identified computationally and then vali-
date experimentally an association between the CAD risk locus rs2107595 and the gene
TWIST1. We propose that the minor allele for this locus can affect transcription factor
binding and provide data supporting a role for TWIST1 in modulating smooth muscle
cell phenotype.
Introduction
Coronary artery disease (CAD) is a complex vascular wall process characterized by progressive
development of atherosclerotic plaques involving multiple cell types. Family and twin studies
estimate the heritability of risk for CAD at 40% to 60% [1]. Genome-wide Association Study
(GWAS) meta-analyses have reported more than 160 genomic loci that are significantly associ-
ated with CAD [2–5]. A subset of these loci are also associated with other phenotypes, includ-
ing lipid traits [6], hypertension, stroke [7], migraine [8], and abdominal aortic aneurysm [9].
The identified GWAS variants are predominantly common single nucleotide polymorphisms
(SNPs) in non-coding regions, which makes the identification of the causal genes and their
underlying connection to pathophysiology challenging. Mapping of expression quantitative
trait loci (eQTLs) has been performed to associate GWAS SNPs with risk genes in vascular
cells and tissues [10–12]. However, atherosclerotic vascular tissues contain multiple cell types.
Cell-specific analysis of eQTLs would considerably advance our understanding of the underly-
ing biology.
We therefore performed transcriptomic analysis and genome-wide genotyping in 19 paired
primary human coronary artery smooth muscle cell (HCASMC) and coronary artery endothe-
lial cell (HCAEC) lines. Using this resource, we performed splicing quantitative trait loci
(sQTL) and allele-specific expression (ASE) analyses to identify and stratify vascular disease
risk genes in these two major cell types of the coronary vessel wall. Additionally, we performed
colocalization analysis between GWAS signals for four vascular traits (CAD, stroke, migraine,
abdominal aortic aneurysm) and eQTL regulated Genes (“eGenes”) in three arterial GTEx tis-
sues (aorta, coronary artery, tibial artery) to identify regulated, disease-relevant genes. As an
example of the potential of this approach, we show a previously unreported association of vari-
ants at the rs2107595 CAD GWAS locus with expression of the TWIST1 gene. We then dem-
onstrate that the rs2107595 locus can regulate TWIST1 expression and provide evidence for a
functional role of TWIST1 in vascular smooth muscle cells.
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Results
Cultured primary vascular cells maintain expression features of primary
tissue
We deep-sequenced the transcriptomes of 19 donor-matched pairs of cultured human coro-
nary artery smooth muscle (HCASMCs) and endothelial cells (HCAECs) (S1 Table). Together
with available transcriptome data from human liver, whole blood, aorta and coronary artery
from the Genotype-Tissue Expression (GTEx) project [13, 14], these were aligned to the
human genome (Ensembl v90, hg19) and analyzed for differential gene expression. Upon
stringent quality control measures, a total of 15 samples with genotype, HCASMC RNA-seq,
and HCAEC RNA-seq were retained for ASE and sQTL analyses. Multi-dimensional scaling
of gene expression data show how both HCASMC and HCAEC samples cluster relative to arte-
rial tissues when compared with liver or whole blood (Fig 1A), and with each other when com-
pared solely with arterial tissue (S1B Fig). Principal component analysis demonstrates that
cell type explains 78 percent of the observed variance, with the second principal component
explaining 4 percent (Fig 1B).
Differential gene expression analysis identified 2091 differentially expressed genes between
the two coronary cell types (Fig 1C), with 753 (HCAEC) and 1,338 (HCASMC) genes meeting
strict filtering criteria (log2 (fold change)�2, adjusted p-value� 0.001, Fig 1D, S2 File). Genes
preferentially expressed in HCASMCs were from lineage-specific pathways such as epithelial-
to-mesenchymal transition, myogenesis, angiogenesis and hepatic fibrosis (Table 1); HCAEC-
specific genes were in Notch, eNOS and VEGF signaling pathways (S2 Table).
Fig 1. Transcriptional profiling of primary HCASMCs and HCAECs. A) Multi-dimensional scaling plot (500 most
differentially expressed genes from RNASeq data from both GTEx–whole blood, liver, aortic and coronary artery
samples–and HCASMC and HCAEC samples) highlights that in vitro cultured primary cells cluster with vascular
tissues and HCASMCs displays a bigger overlap with the primary tissue. B) Principle component analysis of in vitro
cultured coronary artery cells showing 78 percent of the expression variability can be explained by cell type (PC1 –x-
axis). Endothelial cells show less transcriptional diversity than the smooth muscle cells (PC2 –y-axis). HCAECs in red,
HCASMCs in blue. C) Volcano plot of differentially expressed genes distributed by log2 fold change (x-axis) and
adjusted p-value (y-axis). Genes with a positive fold change are overexpressed in HCASMCs relative to HCAECs.
Genes in red meet the significance threshold of adjusted p-value�0.001. D) Venn diagram of genes differentially
expressed in HCASMC and HCAEC at adjusted p-value�0.001 and log2(FoldChange)� -2 or�2.
https://doi.org/10.1371/journal.pgen.1008538.g001
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Splicing quantitative trait locus (sQTL) analysis suggests potential
mechanisms underlying vascular GWAS findings
To examine the effect of GWAS loci for vascular disease on the relative abundance of RNA
splice isoforms, we performed a genome-wide screen for sQTLs in HCAECs and HCASMCs.
Using MAJIQ, which quantifies local splicing variations (LSVs) as percent spliced in (PSI) of
alternatively-spliced mRNA segments, we identified 478 SNPs in 196 genes (SMC) and 1028
SNPs in 359 genes (EC) which were nominally associated (p<0.05) and passed 0.05 FDR cor-
rection at the gene level (S1 File). Combined, these lists included 1399 unique SNPs in 512
genes. Next, we took 3,844 unique genes with at least one nominally significant sQTL in
HCASMC or HCAEC and tested those for sQTL using GTEx artery tissues. Of those, 33057
SNPS in 3310 genes were validated in at least one GTEx tissue at FDR < 0.05. We compared
these lists with the set of SNPs and genes with putative sQTLs passing 0.05 FDR correction at
the gene level in HCASMC and HCAEC. 924 SNPs in 471 genes were reproduced in GTEx,
whereas 475 SNPs in 41 genes were unique to the two cell types (S2A Fig). Finally, we also per-
formed genome wide sQTL analysis for the three artery GTEX tissues and identified 54298
unique SNPs in 7965 genes that passed 0.05 FDR correction at the gene level (S3 File).
The vast majority of GWAS-associated loci for vascular phenotypes have not been function-
ally annotated. Colocalization analysis combines two different data sets to see if related pheno-
types share genetic variants. If a SNP colocalizes between a gene-specific phenotype and a
disease phenotype, there is greater confidence that the variant and gene may be causal for the
disease. We queried for colocalization between published GWAS loci for vascular disease and
the sQTL loci identified above. For sQTL loci identified from HCASMCs and HCAECs, we
found one SNP at the TARS2 gene and 4 SNPs in 3 genes (YAP1, CFDP1, and STAT6) for
HCASMCs and HCAECs, respectively, that passed 0.05 FDR correction at the gene level (S3
Table). All of these variants are in linkage disequilibrium (LD > = 0.8) with SNPs which are
associated with migraine at genome-wide significance. Of these, rs167769 is both associated
with migraine and an sQTL associated with an alternative 5’ splice site in the first exon of five
of the six annotated transcripts of STAT6. This splicing variation affects the 5’ UTR (sQTL
Table 1. Pathway analysis of genes overexpressed in HCASMCs.
GSEA Name Normalized Enrichment Score
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION 2.391177
HALLMARK_MYOGENESIS 1.95380
HALLMARK_ANGIOGENESIS 1.57199
HALLMARK_COAGULATION 1.555932
HALLMARK_HYPOXIA 1.554287
HALLMARK_UV_RESPONSE_DN 1.535091
HALLMARK_GLYCOLYSIS 1.524811
HALLMARK_ESTROGEN_RESPONSE_EARLY 1.509326
HALLMARK_TNFA_SIGNALING_VIA_NFKB 1.469919
HALLMARK_ESTROGEN_RESPONSE_LATE 1.428466
Ingenuity Canonical Pathways Adjusted P-Value
Hepatic Fibrosis / Hepatic Stellate Cell Activation 5.47E-19
Granulocyte Adhesion and Diapedesis 8.85E-05
Axonal Guidance Signaling 1.30E-04
Regulation of the Epithelial-Mesenchymal Transition Pathway 2.83E-04
Agrin Interactions at Neuromuscular Junction 2.83E-04
Acute Phase Response Signaling 2.83E-04
https://doi.org/10.1371/journal.pgen.1008538.t001
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FDR = 0.047) and accounts for approximately 7% increase in inclusion of the 18-nt extension
(S3 Table and S3 Fig).
From the GTEx genome-wide sQTL analysis for arterial tissues described above, we identi-
fied 20 SNPs in 5 genes in aorta, 10 SNPs in 6 genes in coronary artery, and 29 SNPs in 8 genes
in tibial artery achieved genome wide significance for association with their respective diseases
(S2B Fig, S3 Table). Of note, rs324011 is a significant sQTL for STAT6 in all three GTEx tissue
types (sQTL FDR = 0.00351 in aorta, 0.00349 in coronary artery, and 0.00271 in tibial artery).
This variant is in strong LD with rs167769 discussed above (LD score = 0.943414), which asso-
ciates with the same splicing variation in HCAEC but also in aorta and tibial artery (S3 Fig). In
addition, rs324011 was identified as a nominal eQTL for STAT6 in all three GTEx tissue types
(eQTL p = 0.00139 in aorta, 0.0453 in coronary artery, and 4.17x10-5 in tibial artery) (S3
Table). This overlap between sQTL and eQTL was observed for several of the aforementioned
SNPs (see complete table of sQTL and eQTL overlap in S3 File) and may point to mechanistic
connections such as splicing induced frameshifts that lead to nonsense mediated decay and
result in decreased gene expression.
Finally, to identify which of the identified sQTLs may be causal we assessed the associated
SNPs for predicted effect on splicing using ENSEMBL’s Variant Effect Prediction (VEP) tool
[15]. Of the 26769 putative sQTLs called with FDR < 0.05 in any GTEx artery tissue (Aorta,
Coronary artery, or Tibial artery), 488 SNPs in 400 genes lay within range of annotated splice
sites to be scored by MaxEntScan tool (S3 File) [16]. While none of these overlapped with the
sQTLs which were also cardiovascular disease-associated described above, 59 variants were
predicted to have a high impact on splicing (diff> = 1.15 and alt< 6.2 OR diff < = -1.15 and
alt> 8.5, see [4]). The strongest predicted effect is that of rs3762374 (G! A), an intronic vari-
ant located five positions past the 3’ end of DRAM2 cassette exon 2. This variant was previously
flagged as a QTL for both splicing and expression of DRAM2 Lalonde et al 2012], and the alter-
native A allele associates with decreased inclusion of the cassette exon in all three GTEx artery
tissue types (FDR = 7.01x10-36, 3.20x10-13, and 1.04x10-40 in aorta, coronary artery, and tibial
artery, respectively) (S3 Table), in line with the directionality of the MaxEntScan prediction.
This splicing variation affects the 5’ UTR of the two annotated protein-coding transcripts and
may affect translation initiation efficiency.
Allele-specific expression occurs predominantly in arterial eGenes
To identify genetic variants that affect gene expression in cis, we quantified ASE using QuA-
SAR at FDR threshold of 0.05. We observed ASE at 342 SNPs, corresponding to 206 genes in
HCAECs (Fig 2A) and at 63 SNPs, corresponding to 48 genes in HCASMCs (Fig 2B). ASE was
shared across cell types at 27 SNPs (21 genes) (S4 Table). Comparison of these genes with
GTEx data showed many of the ASE genes we identified were also expression quantitative trait
loci (eQTLs) in arterial tissues in GTEx; we refer to these as eGenes. In fact, the majority of
these eGenes overlap between aorta, coronary artery, and tibial artery where 205 of 233 ASE
genes (88%) were also eGenes in all three arterial tissues. Only myosin heavy chain 13
(MYH13), which displayed ASE selectively in HCASMCs, was a GTEx eGene specifically in
coronary artery and not the other arterial tissues.
Colocalization analysis of arterial tissue eGenes and vascular disease-
associated GWAS loci identifies new candidate risk genes
As with sQTL loci, we hypothesized that colocalization analysis of GWAS loci for vascular dis-
ease and eQTLs in arterial tissues may help disentangle gene-rich loci and implicate novel can-
didate genes. We found colocalization with a locus-wide posterior probability threshold of 0.7
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(PP.H4.abf) in 93 variants at 53 gene loci (S5 Table). Of the 53 colocalization genes, TCF21,
MFGE8 and UFL1 also showed ASE in cultured vascular cells. MFGE8 (milk fat globule-EGF
factor 8 protein) is a novel risk gene for CAD and encodes lactadherin and its cleavage product
medin, which comprises the major protein component of aortic medial amyloid (AMA) [17–
19]. UFL1 (UFM1 specific ligase 1) is a novel migraine risk gene involved in ufmylation, a
post-translational modification on lysine residues of proteins, that may play a crucial role in
a number of cellular processes. Its role in migraine is still largely unknown [20]. TCF21 is a
CAD risk gene with a well-established role in HCASMCs [21–23]. Specifically for TCF21,
allele-specific expression of either rs9399114 or rs9402547 (r2 = 1) was correlated with geno-
type at the colocalization lead SNP rs2327426 (p-value = 0.1336, Wilcoxon rank sum test) (Fig
2C, S4A Fig).
GTEx eQTL signals colocalized with CAD-associated variants in 32 cases (20 genes),
stroke-associated variants in 2 cases (2 genes), abdominal aortic aneurysm (AAA)-associated
variants in 6 cases (3 genes), and migraine-associated variants in 53 cases (35 genes) (S6
Table). We identified colocalization signals at several established single trait loci such as
TCF21, ADAMTS7, and LIPA for CAD, and NGF, FHL5, TSPAN2, and SLC24A3 for stroke.
Gene-rich association loci such as VAMP5-VAMP8-GGCX (CAD) and LRP1-STAT6-SDR9C7
(migraine) colocalized only with GGCX and LRP1 in arterial tissues. Some associations co-
occurred in 2 traits (Fig 2D), namely for CAD and stroke at TWIST1, for CAD and AAA at
IL6R, for CAD and migraine at PHACTR1, and for migraine and AAA at LRP1. LRP1 and
IL6R play well-described roles in vascular biology and disease [24, 25]. The association
between PHACTR1 loci and vascular diseases is an ongoing area of investigation [26], and
PHACTR1 locus rs934937 has been linked to both endothelin1 and PHACTR1 genes [27, 28].
However, little is known about the role of TWIST1 in vascular diseases.
We further investigated cases in which colocalization eGenes differed from reported anno-
tated genes at GWAS loci. For example, the reported migraine-associated signal near calcium
Fig 2. Non-coding variation modulating expression in vascular cells and tissues. A) and B) Manhattan plot of
Allele-Specific Expression loci in HCAECs (A) and HCASMCs (B). Genomic coordinates (hg19) are plotted on the x-
axis, Benjamini-Hochberg adjusted p-values (FDR) for each interrogated variant are plotted on the y-axis. SNPs with
FDR� 0.05 are shown in blue and those with FDR� 0.01 in red. C) Allele-Specific Expression of TCF21 based on
colocalization genotype. Allelic expression ratio (A / (A+R) = 0.5) of TCF21 at rs9389114 on the y-axis is associated
with genotype of the lead colocalization variant rs2327426 on the y-axis. HCAECs are shown in red and HCASMCs in
blue. D) Venn diagram of colocalization genes for 4 vascular traits. Coronary Artery Disease (CAD), Stroke (STR),
Abdominal Aortic Aneurysm (AAA) and Migraine (MIG). Numbers in sectors represent the numbers of
colocalization genes per group. HGNC gene names of key association genes are plotted as well.
https://doi.org/10.1371/journal.pgen.1008538.g002
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responsive transcription factor (CARF) displayed colocalization with neurobeachin like 1
(NBEAL1) expression in all three arterial tissues. Rare protein coding variants at NBEAL1 were
recently demonstrated to be associated with raised atherosclerotic lesions in the young [29].
Importantly, the shared stroke and CAD association signal rs2107595 near HDAC9 colocalized
with TWIST1 but not HDAC9 expression in aorta (Fig 3A). In additional to our colocalization
results, the CAD GWAS lead SNP rs2107595 is associated with ischemic heart disease and dis-
ease of the precerebral arteries in UK Biobank dataset (S6B Fig) [30] and with stroke [31],
Moyamoya disease (a rare, progressive cerebrovascular disorder) [32], and peripheral artery
disease (PAD) [33]. We therefore focused on the rs2107595 locus for further characterization.
TWIST1 as novel candidate risk gene for CAD and stroke
Although the lead SNP rs2107595 is shared between CAD (adjusted p-value = 8.05x10-11),
stroke (large vessel disease, adjusted p-value = 2�03×10−16) and Moyamoya disease (adjusted
p-value = 1.49x10-29), the variant associated with PAD in a Japanese population (rs2074633,
adjusted p-value = 8.8x10−8) is in high linkage disequilibrium with rs2107595 in the East Asian
population (r2 = 0.832 (CHB/JPT) / 0.617 (EUR)– 1000G Phase I data). The association signal
is located near the last exon of the HDAC9 gene and has therefore been previously reported as
an HDAC9 association locus. However, rs2107595 is a GTEx eQTL locus for TWIST1 in aorta
(Fig 3B, S4B Fig), and our colocalization analysis showed that this region colocalizes with
TWIST1 (Fig 3A).
In our transcriptome data, although TWIST1 was associated with rs2107595 genotype in
HCAECs but not in HCASMCs (Fig 3C), it was preferentially expressed in HCASMCs versus
HCAECs (S5A Fig). Furthermore, in human carotid plaque samples TWIST1 expression
was positively correlated with SMC markers in human (S5B Fig). In total, four of the SNPs
reaching genome-wide significance for association with CAD in this locus fall into known
enhancers or transcription factor binding sites in HCASMCs. rs2107595 lies in an Assay for
Transposase-Accessible Chromatin using sequencing (ATACseq) site in human aortic smooth
muscle cells as well as an H3K27Ac enhancer in HCASMCs (Fig 3D and 3E) and an H3K27ac
site in mesenchymal stem cells (S6 Fig). Finally, conditional analysis of the association in this
region with CAD indicates that the rs2107595 haplotype is the primary major determinant of
the observed association (Fig 3F).
To evaluate the effect of rs2107595 on TWIST1 expression, the rs2107595 locus was edited
using CRISPR/Cas9 in HEK293T cells. Following transfection with plasmid containing
CRISPR/Cas9 and a guide RNA targeted upstream of variant rs2107595, individual clones
were expanded and evaluated by sequencing of genomic DNA. TWIST1 and HDAC9 expres-
sion were evaluated in each clone with editing at the rs2107595 locus (S7 Fig). Cell lines in
which the rs2107595 was disrupted had decreased TWIST1 expression with no significant
effect on HDAC9 (Fig 4A). To evaluate the role of rs2107595 in HCASMCs specifically, a sin-
gle guide RNA targeting the region at this variant along with a CRISPR-KRAB expression
cassette were transduced by lentivirus into HCASMCs. Epigenetic silencing at rs2107595
decreased TWIST1 expression without affecting HDAC9 expression (Fig 4B).
Based on in silico analyses, the major (protective) allele of rs2107595 harbors an E2F bind-
ing motif, while the minor (risk) allele generates an RBPJ binding motif (S8 Fig). RBPJ is the
major effector of the Notch signaling pathway which is known to be important in vascular
development and disease [34, 35], and to transcriptionally regulate TWIST1 expression [36,
37]. To evaluate RBPJ binding at the rs2107595 locus, we performed chromatin immunopre-
cipitation for RBPJ in HCASMCs and HCAECs from three heterozygous donors. RBPJ bind-
ing at rs2107595 was selectively enriched in HCASMCs relative to HCAECs (Fig 4C). We also
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Fig 3. The TWIST1/HDAC9 association locus for CAD and stroke. A) Colocalization analysis of GWAS association with CAD
(upper panel) and eQTLs for expression of TWIST1 in human aorta (lower panel). The position on Chromosome 7 (hg19) is plotted
on the x-axis, -log10 adjusted P-value on the y-axis. The locus-wide posterior probability that both the GWAS association and the
eQTL association are based on the same SNP(s) (PP.H4.abf) is 0.94158. B) TWIST1 expression in human aorta based on rs2107595
genotype (GTEx v7 data, n = 267). C) TWIST1 expression in HCAECs (n = 14) and HCASMCs (n = 14) based on rs2107595
genotype. D) Genomic locus at the rs2107595 association signal for Coronary Artery Disease (CAD). The upper panel in red
represents SNPs tested for association with CAD. The line demarcates the p-value threshold of genome-wide significance at 5x10-8.
Above are depicted the regions assayed in downstream analyses. The panels below the gene annotation track show regions of
potentially functional chromatin including regions of open chromatic (ATACseq) in HCASMC, enhancers (H3K27ac) as identified
in HCASMC and enhancers identified in multiple ENCODE tissues (E-H3K27ac). E) Close-up of the rs2107595 region. At the top
are shown the region tested in vivo for enhancer function in mouse embryo and below in luciferase reporter assays. The lead
association SNP falls into a putative functional region. F) Conditional analysis at the rs2107595 association locus for CAD before
(left) and after (right) association for linkage. Plotted are all tested SNPs along the genomic coordinate at the locus (x-axis) and their
p-value of significance of association for CAD (left y-axis). The right y-axis shows the recombination rate at the locus as a measure of
linkage disequilibrium.
https://doi.org/10.1371/journal.pgen.1008538.g003
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confirmed that E2F is able to bind to this region (S9B Fig). Allele-specific analysis demon-
strated that RBPJ preferentially binds to the risk allele (Fig 4D, S10 Fig).
We hypothesized that, in contrast to the protective major allele, the risk allele promotes
RBPJ binding at this site resulting in increased transcriptional activity. To test this hypothesis,
we examined an 800 bp genomic region around rs2107595 for transcriptional regulatory activ-
ity using in vitro luciferase reporter assays in HEK293T cells and rat aortic smooth muscle
(A7r5) cells. The genomic region served as a repressor in HEK293T cells and an enhancer in
SMCs, which may be due to differences in cell-specific transcription factors or adaptor pro-
teins [38]. In both cases, the risk allele increased transcriptional activity of the region (Fig 4E
and 4F). Transactivation assays with a constitutively active RBP show that in the presence of
RBPJ, the major (risk) allele is stimulated to a larger extent than the minor (protective) allele
(Fig 4G and 4H).
TWIST1 plays a functional role in SMCs in vitro
To determine a possible role of TWIST1 in vascular disease, we next investigated TWIST1
abundance and function in vascular smooth muscle cells. Using a human pluripotent stem cell
derived neural crest model of in vitro lineage-specific differentiation of vascular smooth mus-
cle cells [39], we found that TWIST1 expression was highest at the SMC progenitor stage, par-
ticularly in neural crest progenitor cells which selectively contribute to formation of the aortic
arch (Fig 5A). TWIST1 expression was decreased in the differentiated SMCs arising from these
Fig 4. Functional annotation of the rs2107595 region in HEK293T, A7r5, and HCASMCs. �p<0.05, �� p< 0.01, ���p<0.001, ����p<0.0001. A)
Clonal HEK293T colonies with disruption of rs2107595 locus with CRISPR genome editing show decreased average TWIST1 expression and no
significant difference in HDAC9 expression.B) CRISPR inhibition (CRISPRi) targeted to rs2107595 in HCASMCs decreased TWIST1 expression with
no significant effect on expression of HDAC9. A single guide directed to the GWAS lead SNP rs2107595 was cloned into a lentiviral plasmid that
encodes dCas9-KRAB and transduced into HCASMC. C) ChIP-qPCR in three separate heterozygous HCAEC and HCASMC lines showed increased
binding of RBPJ to rs2107595 locus in HCASMC compared to HCAECs. D) Allele-specific analysis of RBPJ ChIP was performed in three separate
heterozygous HCASMCs lines. The averaged results shows preferential pull-down of the minor (A, risk) allele of rs2107595. The dashed line marks the
50 percent allelic balance. E, F) The genomic region around rs2107595 serves a regulatory function in both HEK293 cells (repressor) and in A7r5 SMCs
(enhancer) in luciferase reporter assays. In both cases, the minor (risk) allele increases the regulatory function of the region. G,H) When compared with
the major allele, the minor allele showed increased luciferase activity in both HEK293 (G) and A7r5 (H) cells in transactivation assays with a
constitutively active RBPJ-VP16 fusion protein.
https://doi.org/10.1371/journal.pgen.1008538.g004
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progenitors. To determine whether TWIST1 expression could be induced in differentiated
SMCs, and therefore be relevant in adult pathology as well as in development, we stimulated
cells with interleukin (IL)-1β, an inflammatory cytokine upregulated during atherosclerosis
disease progression. Indeed, TWIST1 expression was induced by IL-1β (Fig 5B, S11 Fig).
Since TWIST1 was more highly expressed in SMC progenitor states and was activated by
IL-1β stimulation, we hypothesized that TWIST1 is able to modulate SMC phenotype, driving
SMCs towards a less-differentiated and more proliferative phenotype and away from a more
mature contractile phenotype [40]. To evaluate the effect of TWIST1 on SMC phenotype, we
performed knockdown experiments in HCASMC and overexpression and knockdown experi-
ments in rat aortic smooth muscle cells (A7r5). TWIST1 knockdown using siRNA decreased
proliferation in HCASMC as assessed with EDU assay (Fig 5C). In a cell counting assay,
ectopic Twist1 overexpression, which increased expression 5-fold, increased SMC number
compared to control whereas Twist1 siRNA knockdown decreased cell number over time (Fig
5D and 5E, S12 Fig). As SMCs become mature and differentiated, they can become less prolif-
erative and transition towards a contractile and even osteoblast-like phenotype [41, 42]. We
therefore hypothesized that TWIST1, in driving SMCs to a less differentiated and more prolif-
erative state, would decrease the ability of A7r5 SMCs to form calcifications in response to
phosphate-rich media. Indeed, Twist1 overexpression led to a decreased number of calcifica-
tions, whereas siRNA knockdown of Twist1 increased the calcification potential of A7r5 cells
(Fig 5F).
TWIST1 expression in atherosclerotic lesions in vivo
We next examined TWIST1 in vascular tissues in vivo. In human coronary arteries, TWIST1
protein could be detected in different compartments of the diseased vessel such as adventitia,
media, and the neointima (S13 Fig). TWIST1 mRNA was significantly upregulated in
human carotid arteries displaying atherosclerotic lesions in the Swedish BiKE study (fold
change = 2.616, p-value = 0.0008, n = 137, Fig 5G) [43]. Interestingly, TWIST1 expression was
higher in lesions categorized as asymptomatic based on absence of signs of a transient ischemic
attack prior to endarterectomy (fold change = -0.754, p = 0.0275, n = 127, Fig 5H, S14 Fig).
Immunostaining for TWIST1 in normal carotid arteries and in areas of atherosclerosis show
that low basal TWIST1 expression in medial SMCs was increased in carotid plaques (Fig 5I
and 5J).
Discussion
Previous whole-transcriptome analyses of human coronary arteries and their associations with
vascular diseases have been limited to whole tissue eQTL analyses [12]. However, transcrip-
tome profiling of individual cell types of the human coronary artery vessel wall has two major
advantages. It links individual genes to a distinct cell type and controls for environmental con-
ditions. Because of the important role of both HCASMC and HCAEC in CAD, and their
related developmental origin, we have focused our studies on these two cell types.
Using ASE analysis in HCASMCs and HCAECs, we identified several genes for which
expression levels were modulated by common, non-coding variation in these cells, including
tropomyosin 1 (TPM1), endothelial lipase (LIPG), C-X-C motif chemokine ligand 5 (CXCL5)
and 16 (CXCL16), activated leukocyte cell adhesion molecule (ALCAM) and transcription fac-
tor 21 (TCF21). We found that the majority of ASE genes were also eGenes in arterial tissues
in the GTEx data set and were commonly shared between all three arterial tissues in GTEx
(aorta, coronary artery, and tibial artery). Myosin heavy chain 13 (MYH13) was the only gene
in our study with allele-specific expression in HCASMCs and eQTL association exclusively in
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Fig 5. The role of TWIST1 in vascular cells. A) Heat map showing the differential gene expression of TWIST1 and an early stage
(ACTA2) and late stage (MYH11) differentiation marker of vascular SMCs in an in vitro differentiation model. Values represent
Euclidean distances from the mean across all samples at the different stages. During in vitro differentiation of SMCs, TWIST1
expression is maximal at the neural crest progenitor stage and decreases during smooth muscle cell differentiation. (hESC: human
embryonic stem cells; neuroectoderm: neuroectoderm progenitors; NC_2: neural crest progenitor passage 2; NC_7: neural crest
progenitor passage 7; SMC_2 NC: SMCs derived from NC_2; SMC_7: SMCs derived from NC_7; somite.SMC: SMCs derived from
paraxial mesoderm progenitor; proximal.meso.SMC: SMCs derived from lateral mesoderm progenitor; neuroectoderm.SMC: SMCs
derived from neuroectoderm progenitors). B) Quantitative PCR of TWIST1 expression levels in neural crest (neural crest P7)
progenitor cells and neural crest derived smooth muscle cells (neural crest SMC) with and without stimulation with IL-1β. TWIST1
expression is upregulated in neural crest-derived SMCs after treatment with IL-1β. C) EDU assay of HCASMCs showed decreased
proliferation with knockdown of TWIST1. D,E) Proliferation assay in A7r5 aortic smooth muscle cells: TWIST1 overexpression
increased cell proliferation significantly at 48H and 72H after transfection, whereas TWIST1 siRNA knockdown decreased cell
proliferation at 48H and 72H. F) Calcification assay in A7r5 aortic smooth muscle cells: Twist1 overexpression decreases calcification
and Twist1 knockdown increased calcification based on alizarin red staining. G)–J) TWIST1 expression in human carotid tissue.
TWIST1 is significantly overexpressed in diseased human carotid endarterectomy samples relative to normal arteries (E), and
TWIST1 expression is higher in asymptomatic plaques relative to symptomatic plaques (F). Immunohistochemistry of normal
carotid arteries show that there is low basal TWIST1 expression (red) which colocalizes with smooth-muscle-actin (SMA, green)
positive SMCs in the vessel media (H). TWIST1 expression is increased in SMC-rich regions of carotid plaques (H).
https://doi.org/10.1371/journal.pgen.1008538.g005
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coronary artery. As this tissue has the lowest sample number of all three tissues (nAorta = 267,
nCoronary = 152, nTibial = 388) this observation is likely based on a biological effect rather than
lack of power for the other vascular tissues.
Colocalization analysis also identified several significant associations between GWAS sig-
nals for four different vascular traits and GTEx eGene signals in three arterial tissues. Many of
these genes, such as TCF21, ADAMTS7, LIPA, PHACTR1, IL6R, and LRP1, are well-established
risk genes. However, we found that genes identified in colocalization analysis overlapped no
more than two vascular disease traits. There was only a modest overlap between ASE and colo-
calization genes, with TCF21 as a well-established risk gene, and MFGE8 and UFL1 as novel,
high-confidence candidates. Colocalization analysis also suggested TWIST1 as a causal gene in
the HDAC9/TWIST1 association locus for CAD and stroke. Genome editing validated this
finding. Thus, while constitutive loss of HDAC9 has been shown to protect from atherosclero-
sis in a mouse model [44] and may be involved in regulating disease risk at this locus, our
data link the rs2107595 haplotype with TWIST1 expression, suggesting a role for TWIST1 in
human vascular disease.
The GWAS lead SNP rs2107595 serves as an eQTL for the TWIST1 gene in human aorta
(GTEx data v7), and disrupting or silencing the rs2107595 locus decreases TWIST1 expression.
TWIST1 is a bHLH transcription factor known for its role in epithelial-to-mesenchymal tran-
sition during mesenchymal development and in cancer progression [45, 46]. It is expressed in
the cardiac neural crest [47] and proepicardial organ [48], which are sources of smooth muscle
cell progenitors during coronary development. More specifically, TWIST1 promotes expres-
sion of the CAD-associated gene TCF21 in the pro-epicardial organ [48], and is thus involved
in the development of coronary artery smooth muscle cells. It is also likely involved in diseased
vessel wall SMCs where TCF21 upregulation modulates gene expression, SMC phenotype, and
CAD risk [49]. Though we focus on the role of TWIST1 in SMCs for these reasons, TWIST1
has been implicated in shear stress induced endothelial dysfunction [50, 51] and plays an
important role in endothelial biology. In particular, our data suggest that rs2107595 is an
eQTL for TWIST1 in ECs. The region around rs2107595 is also DNase-hypersensitive in sev-
eral endothelial cell types suggesting it also functions as an enhancer in ECs. However, RBPJ
binding of this region is higher in SMCs than in ECs (Fig 4C) suggesting rs2107595 may affect
EC TWIST1 expression through alternate mechanisms which warrant further investigation.
The rs2107595 risk allele is predicted to create an RBPJ binding site. RBPJ is a well-estab-
lished transcriptional regulatory effector of the canonical Notch signaling pathway. Upon
binding at consensus regulatory sites, it can serve as a transcriptional activator or repressor.
We propose that upon Notch activation, the Notch intracellular cytoplasmic domain (NICD)
can act as a coregulator for RBPJ, resulting in a switch from transcriptional repressor to activa-
tor (Fig 6A). Notch signaling has been shown to play a prominent role in smooth muscle biol-
ogy, vascular development, and disease. Gene knockout experiments in mouse of Notch family
members has shown severe vascular malformations, particularly affecting functionality of vas-
cular smooth muscle cells [52]. For example Notch3 is essential for the formation of functional
arteries and mature smooth muscle cells [53], and NOTCH3 mutations cause cerebral autoso-
mal dominant arteriopathy (CADASIL) with severe alterations of small vessel smooth muscle
cells in humans [54].
Notch signaling directly targets the Twist1 gene via RBPJ binding at its promoter, leading to
upregulation of Twist1 expression in mouse limb bud mesenchymal progenitor cells (MPCs)
[36]. Notch-mediated Twist1 expression is necessary for repression of chondrogenic differenti-
ation of MPCs. This described role for Twist1 in MPCs is in agreement with the expression
profile of human TWIST1 in our in vitro differentiation model. TWIST1 expression is low in
precursor cells and peaks at the neural crest progenitor stage. We see an upregulation of
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TWIST1 expression in SMCs in response to IL-1β, which is in agreement with the model of
smooth muscle de-differentiation and phenotypic switching during atherosclerosis [40]. In
the context of human disease, we locate TWIST1 protein in the adventitia of human coronary
arteries and in the tunica media and neointima of more complex atheromas. This is suggestive
of a re-activation or upregulation of TWIST1 in non-adventitial compartments and/or migra-
tion of TWIST1 expressing cells into the atheroma. Similar to studies in developing heart
valves [55] and cranial mesoderm [56], TWIST1 may activate downstream genes involved in
proliferation, migration and extracellular matrix composition in the developing neointima
of atherosclerotic lesions. This would promote SMC phenotypes such as proliferation and
drive SMCs away from a differentiated phenotype capable of calcification. In support of this
hypothesis we show that Twist1 overexpression in rat aortic smooth muscle cells significantly
increases cell proliferation and decreases calcification whereas Twist1 knockdown by siRNA
decreases proliferation and increases calcification.
The human genetic and genomic data in conjunction with in vitro studies reported here
provide a compelling argument for the identification of TWIST1 as a causal gene for vascular
disease. The minor allele of the rs2107595 variant has been identified as a risk allele and is asso-
ciated with increased TWIST1 expression as shown by eQTL studies in vascular samples col-
lected through GTEx and in cultured HCASMC. As expected, analysis of diseased human
carotid artery samples revealed greater expression of TWIST1, compared to disease free ves-
sels. However, TWIST1 expression was found to be higher in carotid lesions in asymptomatic
compared to symptomatic patients. Interestingly, this observation is consistent with the associ-
ation of the disease allele with stable coronary artery disease over the infarction sub-phenotype
[2]. The effects of modulating TWIST1 in vivo to potentially affect proliferation and calcifica-
tion will likely yield new insights into the role of SMCs in atherosclerosis. While the number of
Fig 6. From SNP to phenotype. A) Proposed mechanism of transcriptional regulation at the rs2107595 locus in the
vessel wall. The major allele (left) is predicted to bind E2F transcription factors which are unresponsive to Notch
signaling. The minor allele (right) creates a consensus RBPJ binding site which promotes TWIST1 gene transcription.
B) The effect of TWIST1 protein on cardiovascular risk. In normal arteries, TWIST1 expression is low in fully
differentiated smooth muscle cells of the tunica media (left). During early atherosclerosis (middle), there is increased
TWIST1 expression in SMCs. This favors a de-differentiated SMC phenotype which increases SMC proliferation and
increases coronary artery disease (right).
https://doi.org/10.1371/journal.pgen.1008538.g006
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HCASMC in plaque has been shown to be inversely correlated with disease risk, this associa-
tion might break down in the case of unbridled proliferation of this cell type (Fig 6B). A salu-
tary effect of HCASMCs in the plaque is hypothesized to result from the ability of medial
SMCs to de-differentiate and migrate into the lesion where they subsequently re-differentiate
and serve a stabilizing effect through cellular integrity and matrix production. Thus, TWIST1
may play a more significant role in plaque burden than in plaque vulnerability. Additionally,
though the role of calcification in plaque stability is complex and involves many cell types
including SMCs [57], our data suggest TWIST1 may affect the ability of SMCs to form
calcifications.
In summary, we report unbiased transcriptional profiling of primary cells to identify novel
risk genes for common vascular diseases with a focus on insufficiently researched, complex
association loci. We propose TWIST1 via the rs2107595 association as a novel risk gene for
CAD, with a vascular causal mechanism related to SMC phenotype.
Materials and methods
Primary cell culture and sample processing
See supplemental materials for details (S1 File). In brief, primary human coronary artery
smooth muscle cells (HCASMC) and human coronary artery endothelial muscle cells
(HCAEC) were obtained from Lonza, Promocell, and Cell Applications (S1 Table). For RNA-
Seq, Total RNA was isolated from confluent cells at passage 2 and prepared for sequencing
using TruSeq Stranded Total RNA Library Prep Kit (Illumina RS-122-2103). The libraries
were sequenced at the University of Pennsylvania Next-Generation Sequencing Core using
paired-end, 100 and 125 nt long reads on an Illumina HiSeq 2500 system. Genomic DNA was
isolated and genotyped on the Illumina Expanded Multi-Ethnic Genotyping Array (Illumina
MEGAEX).
Data analysis
Details of gene expression, gene ontology, pathway, sQTL, allelic-specific expression, and
colocalization analyses are available in the supplemental materials (S1 File). The datasets
generated during and/or analyzed during the current study are available in Gene Expression
Omnibus under accession GSE111120 at https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?
acc=GSE111120.
Generation and analysis of CRIPSR lines
Genome editing of the enhancer region around rs2107595 was performed by CRISPR/Cas9
system as previously reported [58] using guide sequence GGATGAGGAGCCATTACTGT. In
brief, HEK293 cells were seeded into 6 well plate (8×105 cells /well) and cultured in DMEM
with 10% FBS on day 0. On day 1, cells were transfected with 2 μg sgRNA/Cas9-GFP using
7.5 μl Lipofectamine 3000 per well. On day 2, cells were sorted using a Sony SH800s. A subset
of the GFP-positive cells were singly sorted into a 96-well plate and expanded. Clones were
screened for editing at rs2107595 as previously reported [59, 60] and outlined in S1. TWIST1
and HDAC9 gene expression was assessed in positively edited clones using qRT-PCR (S1 File),
and aggregate data for clones with edited rs2107595 is presented.
Biobank of Karolinska Endarterectomies (BiKE) study
Carotid endarterectomies (carotid plaques, CP) were collected at time of surgery from both
symptomatic (S) and asymptomatic (AS) patients and retained within BiKE Study. One cohort
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(referred to as “large dataset”) consisted of Affymetrix microarray profiling of 127 atheroscle-
rotic plaques (87 S and 40 AS patients) and 10 normal arteries. A second non-overlapping
cohort (termed “small dataset”) included 50 plaques (41 from S and 9 from AS patients) and
n = 5 normal arteries (S1 File).
Ethics statement
Human studies from the Biobank of Karolinska Endarterectomies (BiKE) study are approved
by the Ethical Committee of North Stockholm and performed with the following ethical per-
mit numbers dating since 1995: BiKE EPN DNr 95–276/277; DNr 01–199; DNr 02–146; DNr
02–147; DNr 04–225/4; DNr 04–97 5T; DNr 2005/83-31; DNr 2007/281-31/4; DNr 2009/4:2;
DNr 2009/9-31/4; DNr 2009/295–31/2; DNr 2009/512–31/2; DNr 2009/2000-32; DNr 2010/
1022-31/1; DNr 2010/730-31/2; DNr 2011/196-31/1; DNr 2011/629–32; DNr 2011/950-32;
DNR 2012/619–32; DNr 2012/916-31/4; DNr 2012/1096-31/2; DNr 2012/1279-32; 2013/615-
31/4; DNr 2012/2188-31-5; DNr 2013/2048-32; DNr 2013/2137–32; 2015/1338-32; DNr 2015/
2108-31/5; Dnr 2017/508-32. All human samples and data in BiKE are collected with written
informed consent from patients or organ donors’ guardians. Tissue and blood sampling is
conducted as part of the ordinary medical and surgical procedures and does not put the
patients at unnecessary risk.
Supporting information
S1 File. Supplemental materials. Supplemental materials file includes additional detailed
materials and methods.
(DOCX)
S2 File. Differential gene expression. Differential Gene Expression file includes the list of
genes that are differentially expressed between HCAECs and HCASMCs with |log2(fold
change)|>2 and adjusted p-value < 0.001.
(XLSX)
S3 File. Splicing quantitative trait loci analysis. The sQTL Analysis file includes the results
from the sQTL analysis including cell-type and tissue-specific putative sQTLs passing
FDR< 0.05 and Variant Effect Predictor.
(XLSX)
S1 Fig. Gene expression from HCAECs and HCSMCs. A) Fold difference in expression of
endothelial cell markers and smooth muscle cell markers from the RNASeq data in 19 paired
samples. Endothelial genes are presented in black as the ratio of TPMs in HCAECs versus
HCSMCs, and Smooth muscle genes are presented in grey as the ratio of TPMs in HCASMCs
to HCAECs. B) Multi-dimensional scaling plot of the 500 most differentially expressed genes
from GTEX RNA-Seq data from 205 aortic (pink) and 117 coronary artery (violet) samples as
well as 19/20 in vitro cultured HCASMC (blue) and HCAEC (red) samples reveals significant
overlap between human aortic and coronary artery tissues. HCAECs and HCSMCs cluster sep-
arately from each other with ECs showing tighter clustering among samples. Both types of pri-
mary cell lines cluster separately from arterial tissue, which may be due to the artificial nature
of the in vitro environment.
(TIF)
S2 Fig. sQTL analysis identifies loci associated with RNA splice variability. A) UpSet plot
of genes with sQTLs in the HCSMC (SMC), HCAEC (EC) and GTEx datasets (FDR< 0.05,
regression test). Vertical bars represent the count of unique genes per set. Below the bar
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graphs, each dot represents a dataset and intersecting sets are represented by lines connecting
dots. Horizontal bars represent the total number of genes with putative sQTLs in each dataset.
B) UpSet plot of all genes with putative sQTLs in the HCASMC/HCAEC and GTEx cohorts
that colocalize with any signal for association with cardiovascular disease.
(TIF)
S3 Fig. sQTL association between STAT6 and rs167769 in HCAEC and GTEx tibial artery.
A) Splicegraph structure of STAT6 near the 5’ end, showing the implicated LSV targeting
exon 6. Inset zooms in on the relevant exons and splice junctions (not to scale). B)—C)
Scatterbox plots of PSI for the alternative 5’ splice site event in STAT6 exon 3, which is the first
exon in the majority of transcripts of STAT6, using data from HCAEC and GTEx, respectively.
Each plot represents samples of the indicated genotype at rs167769. Each green point represent
inclusion level (PSI) quantified in a sample of the LSV’s green junction in A. D) RNA-seq
reads mapping to the alternative 5’ splice site event at the canonical first exon of STAT6 (pur-
ple and green junctions in A). Tracks are labeled with the dataset of origin and sample geno-
type at rs167769 (HCAEC) or rs324011 (GTEx coronary artery). Representative samples were
randomly selected from the pool of all samples with the indicated genotype in their respective
dataset. Reads mapping into the canonical exon body are outlined in a red box. Reads mapping
to the 18-nt extension are immediately to the right of this box. The UCSC transcript annota-
tion track is depicted on the bottom for reference; the bottommost transcript uses a different
first exon not depicted.
(TIF)
S4 Fig. ASE/Colocalization association plots for UFL1, MFGE8 and TCF21 loci, red dot
represent p value < 5e-08 and blue dots represent p value < 1e-06.
(TIF)
S5 Fig. Expression of TWIST1 in HCASMCs and human carotid plaque samples. A)
TWIST1 is increased in SMCs relative ECs based on both RNASeq data and qRTPCR. Immu-
nocytochemistry shows nuclear TWIST1 staining in ACTA2-positive SMCs. B) Expression of
TWIST1 is positively correlated with SMC markers (red) and negatively correlated with EC
and immune cell markers (blue) in human atherosclerotic plaque samples from the BiKE
study.
(TIF)
S6 Fig. Genomic neighborhood and PheWAS of rs2107595. A) UCSC Browser view display-
ing the genomic landscape around GWAS SNP rs2107595 (box). H3K27ac histone modifica-
tion ChIP-Seq data from bone-marrow derived mesenchymal stem cells from the ENCODE
project is also displayed. There is high H3K27ac at this locus which indicates that this area is
likely an active enhancer. B) Phenome-Wide Association Study data from the UK Biobank
shows that rs2107595 is significantly associated with three common vascular disease pheno-
types.
(TIF)
S7 Fig. Overview of CRISPR/Cas9 genome editing near rs2107595 and the effect of dis-
rupting rs2107595 on expression of TWIST1 and HDAC9. A) The wildtype sequence shows
rs2107595 (yellow), PAM sequence (red) and the cut site within the guide RNA sequence (blue
arrowhead). Representative sequences for editted clones are aligned below to show the effects
of CRISPR/Cas9 editing in this genomic region. B) A summary of all clones generated and
used for analysis show a range of insertion/deletions. In all cases, rs2107595 is either missing
or editted (as in clone F2). C) TWIST1 and HDAC9 gene expression is shown for each cell line
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relative to control. Disruption of rs2107595 decreased TWIST1 expression in most cell lines.
(TIF)
S8 Fig. In Silico analysis of transcription factor binding at rs2107595. A) Overview of pro-
posed transcription factor binding to the major and minor alleles based on Transfact Profes-
sional (2014.4 data release). B) Using JASPAR, an open-access database of transcription factor
binding profiles, we find that if there is a G at the rs2107595 locus (and C on the complemen-
tary strand), this base pair forms part of an E2F binding motif. The E2F position matrix shows
that if this is converted to a T, E2F will bind ~ 5% of the time (top yellow box). When the
minor allele is present, and there is a T on the complementary strand of the locus, this base
pair forms part of an RBPJ binding motif. The corresponding RBPJ position weight matrix
shows that a C at this position would result in RBPJ binding ~ 0.5% of the time (bottom yellow
box).
(TIF)
S9 Fig. Chromatin-Immunoprecipitation (CHIP) qPCR analysis of RBPJ and E2F binding.
A) ChIP was performed using RBPJ antibody and IgG controls on heterozygous HCASMCs
and HCAECs. A region 17kb upstream of rs2107595 was amplified to serve as negative control.
As expected, there was no significant enrichment of this area with RBPJ relative to IgG control.
B) ChIP was performed using three different E2F antibodies (E2F1, E2F2, E2F4) as well as IgG
control on heterozygous HCSMCs. qPCR of the region around rs2107595 shows significant
enrichment with E2F4 suggesting E2F4, but not E2F1 or E2F2, binds this region.
(TIF)
S10 Fig. ChIP-PCR restriction fragment length polymorphism analysis. Chromatin-Immu-
noprecipitation was performed using RBPJ on heterozygous HCASMCs. The region surround-
ing rs2107595 was amplified and cloned into sequencing vectors. PCR digestion of 22 colonies
show that RBPJ is preferentially binding the risk (A) allele (17/22 colonies).
(TIF)
S11 Fig. MYH11 expression in neural crest progenitor cells and derived smooth muscle
cells with or without IL-1β treatment. Progenitor cells express less MYH11 than derived
SMC cells, and that MYH11 does not increase in response to IL1B.
(TIF)
S12 Fig. Ectopic TWIST1 overexpression and siRNA knockdown. A) CMV6-promoter
driven TWIST1 overexpression ((pTWIST1) resulted in a ~ 5-fold increase in TWIST1 gene
expression. B) TWIST1 protein is increased as well in HEK293T cells. WM: Western Marker,
PM: Prestained Marker. C) SiRNA knockdown of TWIST1 resulted in ~95% decrease in
TWIST1 gene expression. D) TWIST1 overexpression and knockdown at 24H and 48H had
no consistent effect on apoptosis or necrosis.
(TIF)
S13 Fig. TWIST1 expression in atherosclerotic human coronary arteries samples. TWIST1
protein (blue) is present in the media (M) and in the plaque. L = Lumen; N = Neointima,
M = Media; A = Adventitia.
(TIF)
S14 Fig. TWIST1 expression in human endarterectomy samples, small cohort replication.
A) Twist1 is higher in carotid plaques relative to normal arteries. B) There is a trend towards
decreased Twist1 expression in symptomatic lesions relative to asymptomatic lesions.
(TIF)
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S1 Table. Primary human cell lines.
(XLSX)
S2 Table. Pathway analysis of genes overexpressed in HCAECs.
(XLSX)
S3 Table. Summary of sQTL results that colocalize with GWAS loci for vascular disease for
both primary culture data form HCSMACs and HCAECs and for GTEx arterial tissue
(CA = coronary artery, TA = tibial artery). Each row represents an association statistic
between a SNP and a local splicing variation (LSV) within a gene. SNP-gene pairs are filtered
such that if a SNP is found to associate with multiple LSVs in the same gene, only the most sig-
nificant association is reported. It is expected that LSVs within the same gene may highly cor-
related. The full sQTL output for all tests is attached as supplemental file (S3 File) and includes
all SNP-LSV pairs passing the indicated significance threshold even in cases where the SNP
associates with multiple LSVs in the same gene.
(XLSX)
S4 Table. ASE in heterozygous HCASMC and HCAEC lines. Table includes the position
of all SNPs that showed ASE, corresponding gene annotation, cell type in which ASE was
observed, whether this was a GTEx eGENE or GWAS colocalization site, and the average
number of reads obtained for the major or reference (REF) and the minor or alternate (ALT)
alleles. GTEx eGene tissues: A = Artery_Aorta; C = Artery_Coronary; T = Artery_Tibial.
GWAS colocalization traits: CAD = Coronary Artery Disease; MIG = Migraine.
(XLSX)
S5 Table. Colocalization analysis of 4 vascular GWAS trait associations and 3 arterial
GTEx eQTL signals.
(XLSX)
S6 Table. Significant colocalization of top GWAS SNPs with GTEx eQTLs.
(XLSX)
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